Worldwide Biotech: Serving Small To Midsize Biotech For 30+ Years
The success statistics for emerging biopharmas and biotechs are daunting. Developing a new prescription medicine that gains marketing approval is estimated to cost drugmakers $2.6 billion, and the approval rate for drugs entering clinical development is less than 12 percent.
Given the time, expense, and risk, your choice of a development partner can be the deciding factor in your speed to market, economies of scale, and successful navigation of regulatory requirements.
Worldwide offers experience in delivering the scientific and operational expertise, flexibility, innovation, personal service, and executive support and engagement successful biotechs demand of their development partner.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.